Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia.
Mol Pharm
; 19(3): 895-903, 2022 03 07.
Article
in En
| MEDLINE
| ID: mdl-35113575
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Estonia
Country of publication:
Estados Unidos